Wang, Zhenghang
Peking University Cancer Hospital
4 papers on CoChatORCID 0000-0001-8307-693X
Most cited papers
- Verified
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Qi, C., Gong, J., Li, J., Liu, D., Qin, Y., Ge, S., Zhang, M., Peng, Z., Zhou, J., Cao, Y., et al. (2022) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 604
- Verified
Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors
Xu, T., Wang, X., Wang, Z., Deng, T., Qi, C., Liu, D., Li, Y., Ji, C., Li, J., & Shen, L. (2022) · Therapeutic Advances in Medical Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 38
- Verified
Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
Xu, T., Li, J., Wang, Z., Zhang, X., Zhou, J., Lu, Z., Shen, L., & Wang, X. (2023) · Cancer Medicine
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 20
- Verified
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
Li, J., Wang, Z., Huang, J., Ba, Y., Cao, B., Luo, S., Li, W., Bai, C., Song, Z., Xiong, J., et al. (2026) · The Lancet Gastroenterology & Hepatology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free